197 related articles for article (PubMed ID: 6284780)
1. Synthesis and glycosylation of proopiomelanocortin by a Cushing tumor.
Miller WL; Johnson LK
J Clin Endocrinol Metab; 1982 Sep; 55(3):441-6. PubMed ID: 6284780
[TBL] [Abstract][Full Text] [Related]
2. A pituitary tumor producing high molecular weight adrenocorticotropin-related peptides: clinical and cell culture studies.
Fuller PJ; Lim AT; Barlow JW; White EL; Khalid BA; Copolov DL; Lolait S; Funder JW; Stockigt JR
J Clin Endocrinol Metab; 1984 Jan; 58(1):134-42. PubMed ID: 6315755
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of asparagine-linked glycosylation of pro-opiomelanocortin in mouse pituitary cells by DL-threo-beta-fluoroasparagine.
Phillips MA; Stern AM; Abeles RH; Tashjian AH
J Pharmacol Exp Ther; 1983 Jul; 226(1):276-81. PubMed ID: 6864547
[TBL] [Abstract][Full Text] [Related]
4. Effect of tunicamycin on the synthesis, processing, and secretion of pro-opiomelanocortin peptides in mouse pituitary cells.
Budarf ML; Herbert E
J Biol Chem; 1982 Sep; 257(17):10128-35. PubMed ID: 6286640
[TBL] [Abstract][Full Text] [Related]
5. Glycosylation events in the processing and secretion of pro-ACTH-endorphin in mouse pituitary tumor cells.
Phillips MA; Budarf ML; Herbert E
Biochemistry; 1981 Mar; 20(6):1666-75. PubMed ID: 6261804
[No Abstract] [Full Text] [Related]
6. Differential release of proopiomelanocortin-derived peptides from the human pituitary: evidence from a panel of two-site immunoradiometric assays.
Gibson S; Crosby SR; Stewart MF; Jennings AM; McCall E; White A
J Clin Endocrinol Metab; 1994 Apr; 78(4):835-41. PubMed ID: 8157708
[TBL] [Abstract][Full Text] [Related]
7. Demonstration of in vivo synthesis of pro-opiomelanocortin-, beta-endorphin-, and alpha-melanotropin-like species in the adult rat brain.
Liotta AS; Advis JP; Krause JE; McKelvy JF; Krieger DT
J Neurosci; 1984 Apr; 4(4):956-65. PubMed ID: 6325609
[TBL] [Abstract][Full Text] [Related]
8. An immunoperoxidase study of a human pituitary adenoma associated with Cushing's syndrome.
Wowra B; Peiffer J
Pathol Res Pract; 1984 Mar; 178(4):349-54. PubMed ID: 6328462
[TBL] [Abstract][Full Text] [Related]
9. Coordinate, equimolar secretion of smaller peptide products derived from pro-ACTH/endorphin by mouse pituitary tumor cells.
Mains RE; Eipper BA
J Cell Biol; 1981 Apr; 89(1):21-8. PubMed ID: 6262331
[TBL] [Abstract][Full Text] [Related]
10. [Ectopic secretion of ACTH and of related peptides (LPHs, beta-endorphin, "16K"). Evidence for a common precursor].
Bertagna X; Nicholson WE; Mount CD; Orth DN; Girard F; Bricaire H
Horm Res; 1980; 13(4-5):291-301. PubMed ID: 6268515
[TBL] [Abstract][Full Text] [Related]
11. Unrestrained production of proopiomelanocortin (POMC) and its peptide fragments by pituitary corticotroph adenomas in Cushing's disease.
Bertagna X
J Steroid Biochem Mol Biol; 1992 Oct; 43(5):379-84. PubMed ID: 1327071
[TBL] [Abstract][Full Text] [Related]
12. Corticotropin releasing factor (CRF): effects on the release of pro-opiomelanocortin (POMC)-related peptides by human anterior pituitary cells in vitro.
Chan JS; Lu CL; Seidah NG; Chretien M
Endocrinology; 1982 Oct; 111(4):1388-90. PubMed ID: 6288359
[TBL] [Abstract][Full Text] [Related]
13. Corticotropin-releasing hormone, proopiomelanocortin, and glucocorticoid receptor gene expression in adrenocorticotropin-producing tumors in vitro.
Suda T; Tozawa F; Dobashi I; Horiba N; Ohmori N; Yamakado M; Yamada M; Demura H
J Clin Invest; 1993 Dec; 92(6):2790-5. PubMed ID: 8254033
[TBL] [Abstract][Full Text] [Related]
14. Proopiolipomelanocortin peptides in normal pituitary, pituitary tumor, and plasma of normal and Cushing's horses.
Wilson MG; Nicholson WE; Holscher MA; Sherrell BJ; Mount CD; Orth DN
Endocrinology; 1982 Mar; 110(3):941-54. PubMed ID: 6276164
[TBL] [Abstract][Full Text] [Related]
15. Impaired processing of proopiomelanocortin in corticotroph macroadenomas.
Gibson S; Ray DW; Crosby SR; Dornan TL; Jennings AM; Bevan JS; Davis JR; White A
J Clin Endocrinol Metab; 1996 Feb; 81(2):497-502. PubMed ID: 8636257
[TBL] [Abstract][Full Text] [Related]
16. Two Distinctive POMC Promoters Modify Gene Expression in Cushing Disease.
Araki T; Tone Y; Yamamoto M; Kameda H; Ben-Shlomo A; Yamada S; Takeshita A; Yamamoto M; Kawakami Y; Tone M; Melmed S
J Clin Endocrinol Metab; 2021 Aug; 106(9):e3346-e3363. PubMed ID: 34061962
[TBL] [Abstract][Full Text] [Related]
17. ACTH, beta-LPH and beta-endorphin in pituitary adenomas of the patients with Cushing's disease: activation of beta-LPH conversion to beta-endorphin.
Suda T; Abe Y; Demura H; Demura R; Shizume K; Tamahashi N; Sasano N
J Clin Endocrinol Metab; 1979 Sep; 49(3):475-7. PubMed ID: 224076
[TBL] [Abstract][Full Text] [Related]
18. In vitro secretion of pro-opiomelanocortin (POMC) derived peptides in human ACTH-producing pituitary adenomas: evaluation of hormone ratios in different functional states.
Westphal M; Lüdecke DK
Mol Cell Endocrinol; 1984 Sep; 37(2):145-51. PubMed ID: 6092171
[TBL] [Abstract][Full Text] [Related]
19. Evidence for a peptide similar to 16K fragment in man. Its relationship to ACTH.
Bertagna X; Girard F; Seurin D; Luton JP; Bricaire H; Mains RE; Eipper BA
J Clin Endocrinol Metab; 1980 Jul; 51(1):182-4. PubMed ID: 6247363
[TBL] [Abstract][Full Text] [Related]
20. [Synthesis and release of CRF and ACTH in ectopic CRF/ACTH-producing tumors].
Suda T
Nihon Naibunpi Gakkai Zasshi; 1994 Jan; 70(1):17-24. PubMed ID: 7958079
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
